ImClone To Pay $65M To End Erbitux Suit
ImClone Systems Inc. will shell out $65 million as part of a settlement with Repligen Corp. and the Massachusetts Institute of Technology to resolve Repligen and MIT's 2004 patent suit against...To view the full article, register now.
Already a subscriber? Click here to view full article